Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • RIP kinase
    (3)
  • Apoptosis
    (2)
  • Autophagy
    (1)
  • E3 Ligase Ligand-Linker Conjugates
    (1)
  • Endogenous Metabolite
    (1)
  • Ferroptosis
    (1)
  • IDO
    (1)
  • Indoleamine 2,3-Dioxygenase (IDO)
    (1)
  • Liposome
    (1)
  • Others
    (6)
TargetMol | Tags By ResearchField
  • Cancer
    (3)
  • Infection
    (1)
Filter
Search Result
Results for "

nec1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | All_Pathways
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    4
    TargetMol | Recombinant_Protein
  • Antibody Products
    1
    TargetMol | Antibody_Products
Necrostatin-1
Necrostatin 1, Nec-1
T18474311-88-0
Necrostatin-1 (Nec-1) is a specific RIP1 inhibitor and necrotic apoptosis inhibitor, which inhibits TNF-α-induced necrotic apoptosis and also inhibits IDO.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Necrostatin 2 racemate
Necrostatin-2 racemate
T7504852391-15-2
Necrostatin 2 racemate (Necrostatin-2 racemate) is an potent and specific inhibitor of RIPK1.
  • $59
In Stock
Size
QTY
TargetMol | Citations Cited
Thalidomide-amine-C11-acid
T2123262411665-33-1
Thalidomide-amine-C11-acid is an E3 ligase ligand-linker conjugate composed of Thalidomide 5-fluoride and a linker. This compound is utilized in the synthesis of JQAD1.
  • Inquiry Price
10-14 weeks
Size
QTY
L-threo-Sphingosine C-18
T2291725695-95-8
L-threo-Sphingosine C-18 is a protein kinase C inhibitor.
  • $430
35 days
Size
QTY
Cl-Necrostatin-1
T68520862377-51-3
Cl-Necrostatin-1 is an inhibitor of receptor-interacting protein kinase. It inhibits RIPK1 activity.
  • $178
35 days
Size
QTY
Lysophosphatidylcholine C19:0
1-Nonadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine
T81895108273-88-7
Lysophosphatidylcholine C19:0 (1-Nonadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine), an acyl chain lipid, enhances IL-1beta secretion [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Sphingosine (d15:1)
D-erythro-Sphingosine C-15
T8450986555-28-4
Sphingosine (d18:1), an amino alcohol, is chiefly recognized for its 18-carbon unsaturated hydrocarbon chain. Nevertheless, in mammalian tissues, both sphingosine and its variant, dihydrosphingosine, feature hydrocarbon chains ranging from 12 to 26 carbons. Sphingosine (d15:1) represents a naturally rare variant, serving as an internal standard for chromatographic or spectrometric analyses of sphingoid compounds.
  • $155
35 days
Size
QTY
Necrostatin-1 (inactive control)
Nec-1 (inactive control)
T8472764419-92-7
Necrostatin-1 (Nec-1) (inactive control), an inactive analog of Necrostatin-1, functions as a potent inhibitor of necroptosis [1].
  • $79
35 days
Size
QTY
Sphingosine (d16:1)
D-erythro-Sphingosine C-16
T850106982-09-8
Sphingosine (d16:1), an unconventional sphingolipid, is synthesized through enzymatic reactions starting with the condensation of myristoyl-CoA and serine by serine palmitoyltransferase long-chain base subunit 3 (SPTLC3), which shows a preference for myristoyl-CoA. This compound is found in minute quantities in its free form in human plasma and as a component of various plasma sphingolipids, such as sphingosine-1-phosphate, ceramides, sphingomyelins, and in brain cerebrosides, albeit at lower concentrations than the more common d18:1 sphingoid base. Sphingosine (d16:1) acts as an inhibitor of PKC in mixed micelle assays and diminishes superoxide production triggered by phorbol 12-myristate 13-acetate in isolated human neutrophils, as well as inhibiting the growth of CHO cells with IC50 values of 1 and 3.2 µM, respectively. Additionally, the concentration of sphingolipids containing sphingosine (d16:1) in the plasma is linked to the dietary consumption of saturated fatty acids and protein among ethnic Chinese populations.
  • $75
35 days
Size
QTY
18:0-LPS
Lysophosphatidylserine C18:0
TN9956119786-67-3
18:0-LPS (Lysophosphatidylserine C18:0) is an endogenous lipid identified during the oxidation of phospholipids. It holds potential for use in cardiovascular disease research.
  • Inquiry Price
10-14 weeks
Size
QTY